Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

4.705 +0.225 (+5.02%)
Streaming Delayed Price Updated: 11:05 AM EDT, Mar 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 223,657
Open 4.520
Bid (Size) 4.700 (900)
Ask (Size) 4.710 (400)
Prev. Close 4.480
Today's Range 4.520 - 4.750
52wk Range 2.370 - 6.180
Shares Outstanding 136,360,208
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
Anniversary Milestone Highlights Expanded Manufacturing Capacity, Stronger Asia-Pacific Presence, and Measurable Contributions to Global Supply Chain Resilience 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗
Cytek (CTKB) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade

Performance

YTD
-4.4%
-4.4%
1 Month
+6.2%
+6.2%
3 Month
-7.7%
-7.7%
6 Month
+21.9%
+21.9%
1 Year
+11.5%
+11.5%

More News

Read More
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗
Via Chartmill
News headline image
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
Via Benzinga
News headline image
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock ↗
Via Benzinga
News headline image
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For May 8, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
Via Benzinga
News headline image
Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Cytek Biosciences Reports First Quarter 2025 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November ↗
Via Benzinga
News headline image
Crude Oil Gains 1%; Chicago PMI Falls In December ↗
Via Benzinga
News headline image
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
From Cytek Biosciences, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Cytek Biosciences, Inc. - Common Stock publicly traded?
Yes, Cytek Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Cytek Biosciences, Inc. - Common Stock trade on?
Cytek Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytek Biosciences, Inc. - Common Stock?
The ticker symbol for Cytek Biosciences, Inc. - Common Stock is CTKB on the Nasdaq Stock Market
What is the current price of Cytek Biosciences, Inc. - Common Stock?
The current price of Cytek Biosciences, Inc. - Common Stock is 4.705
When was Cytek Biosciences, Inc. - Common Stock last traded?
The last trade of Cytek Biosciences, Inc. - Common Stock was at 03/23/26 11:05 AM ET
What is the market capitalization of Cytek Biosciences, Inc. - Common Stock?
The market capitalization of Cytek Biosciences, Inc. - Common Stock is 641.57M
How many shares of Cytek Biosciences, Inc. - Common Stock are outstanding?
Cytek Biosciences, Inc. - Common Stock has 642M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.